PDS Biotechnology Corporation
PDSB
$1.32
$0.0251.94%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.13% | -6.75% | 25.86% | -28.80% | 21.46% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 4.86% |
| Total Amortization of Deferred Charges | 308.66% | -8.46% | -2.39% | 7.51% | 5.03% |
| Total Other Non-Cash Items | -69.26% | -11.36% | -7.54% | -13.79% | 26.55% |
| Change in Net Operating Assets | 45.63% | -2.20% | -456.33% | 121.73% | -131.44% |
| Cash from Operations | -0.76% | -9.69% | -2.93% | 9.69% | 10.87% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -527.51% | -0.01% | -22,165.25% | -2.17% | -2.22% |
| Issuance of Common Stock | -79.99% | 120.41% | 10,482.11% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Financing | -86.40% | 4,136.86% | 904.65% | 224.64% | -100.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -373.74% | 78.78% | -0.99% | 10.32% | -188.35% |